Skip to main content
Log in

Megaloblastic Anemia Presenting with Massive Reversible Splenomegaly

  • Case Report
  • Published:
Indian Journal of Hematology and Blood Transfusion Aims and scope Submit manuscript

Abstract

Megaloblastic anemia (MA) is a common disorder with varied manifestations. It generally results in mild to moderate splenomegaly which is due to sequestration of macrocytic erythrocytes in spleen. Massive splenomegaly is generally seen in infections, myeloproliferative diseases, neoplasms, storage disorders or hematological conditions; but is not heard of and has rarely been reported in MA. We discuss a case of massive splenomegaly who presented with symptomatic anemia and was found to have MA. He was extensive evaluated for all other causes of massive splenomegaly which was normal. Further, after a therapeutic trial of MA he showed a regression in spleen size confirming that the massive splenomegaly was attributable to MA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

References

  1. Greer JP, Forester J, Rodgers GM, Paraskevas F et al (eds) (2009) Wintrobe’s clinical hematology, 12th edn. Lippincott Williams & Wilkins, Philadelphia, pp 1143–1172

    Google Scholar 

  2. Longo D, Fauci A, Kasper D (2012) Harrisons principles of internal medicine, 18th edn. The McGraw-Hill Companies Inc, New York, pp 862–871

    Google Scholar 

  3. MacCarty WC (1928) Chronic splenomegaly. Arch Intern Med 41:536–548

    Article  Google Scholar 

  4. Pruthi RK (1993) Reversible marked splenomegaly in pernicious anemia. Ann Intern Med 119:1053

    Article  CAS  PubMed  Google Scholar 

  5. Enokihara H, Saito K, Hazama S, Hirose K, Komatsu H, Furusawa S et al (1978) A case of pernicious anemia with giant splenomegaly. Jap J clin hematol 19(12):1684–1689

    CAS  Google Scholar 

  6. O’Reilly RA (1998) Splenomegaly in 2,505 patients at a large university medical centre. West J Med 169:78–87

    PubMed Central  PubMed  Google Scholar 

  7. Bigg E (1940) Spleen size in pernicious anemia. Ann Intern Med 14:277–280

    Article  Google Scholar 

  8. Limal N, Scheuermaier K, Tazi Z, Sene D, Piette JC, Cacoub P (2006) Hyperhomocysteinaemia, thrombosis and pernicious anaemia. Thromb Haemost 96(2):233–235

    CAS  PubMed  Google Scholar 

  9. Fernández-Ruiz M, Alonso-Navas F, Muro E, Pérez-Carreras M (2011) Portal and mesenteric vein thrombosis associated with hyperhomocysteinemia and pernicious anemia in a patient heterozygous for the MTHFR C677T mutation. Med Clin (Barc) 136(5):225–226

    Article  Google Scholar 

  10. Erkurt MA, Aydogdu I, Dikilitaş M, Kuku I, Kaya E, Bayraktar N et al (2008) Effects of cyanocobalamin on immunity in patients with pernicious anemia. Med Princ Pract 17(2):131–135

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Vineet Behera.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Behera, V., Randive, M., Sharma, P. et al. Megaloblastic Anemia Presenting with Massive Reversible Splenomegaly. Indian J Hematol Blood Transfus 31, 297–299 (2015). https://doi.org/10.1007/s12288-014-0461-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12288-014-0461-6

Keywords

Navigation